Trelleborg acquires US healthcare & medical company

Trelleborg Group has, through its business area Trelleborg Sealing Solutions, signed an agreement and finalized the acquisition of the US-based company EirMed, LLC. The company specializes in technical precision plastic injection-molded components, which are mainly applied in medical devices, such as those used for in-vitro diagnostics, minimally invasive surgery, and orthopedics.


The company has its head office and manufacturing in Menomonie, Wisconsin, in the US. Sales amounted to approximately SEK 100 M in 2021.


The healthcare & medical market is expected to report stable and strong growth in the years ahead. For Trelleborg, the bolt-on acquisition is part of its strategy to grow in attractive industries that have high entry barriers, and which complement and strengthen its existing offerings.


“EirMed is a welcome addition in our process of building a larger and more complete offering in healthcare & medical. The market for technical polymer-based precision components is a strategically important area for us. The acquisition gives us access to new markets, applications and customers, while EirMed’s solutions will gain access to our broad sales channels. The company also has exciting development projects in bioresorbable polymers,” says Peter Hahn, President of the Trelleborg Sealing Solutions business area.


The ongoing macro trends in healthcare & medical, such as an aging population and a growing global middle class, are driving higher technological content in both health and medical care, as well as the medtech industry.


The transaction is consolidated as of April 25, 2022.